Upcoming Changes to the Mifepristone REMS Program: Implications for Pharmacy Practice
Birth Control Pharmacist
JANUARY 24, 2022
In the coming months, mifepristone (Mifeprex) is anticipated to have an updated Risk Evaluation and Mitigation Strategy (REMS) Program that allows dispensing through local brick-and-mortar and mail-order pharmacies. Forthcoming FDA Update to the Mifepristone REMS Program. Background.
52 
Let's personalize your content